231 related articles for article (PubMed ID: 33203641)
1. COVID-19 cytokine storm: what is in a name?
Nigrovic PA
Ann Rheum Dis; 2021 Jan; 80(1):3-5. PubMed ID: 33203641
[No Abstract] [Full Text] [Related]
2. Prevention of the cytokine storm in COVID-19.
Wright DJM
Lancet Infect Dis; 2021 Jan; 21(1):25-26. PubMed ID: 32386610
[No Abstract] [Full Text] [Related]
3. COVID 19: in the eye of the cytokine storm.
Liuzzo G; Patrono C
Eur Heart J; 2021 Jan; 42(2):150-151. PubMed ID: 33462598
[No Abstract] [Full Text] [Related]
4. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the
López-Iranzo FJ; López-Rodas AM; Franco L; López-Rodas G
Curr Pharm Des; 2020; 26(35):4515-4521. PubMed ID: 32787748
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
Azar MM; Shin JJ; Kang I; Landry M
Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
[TBL] [Abstract][Full Text] [Related]
7. Calming the cytokine storm in COVID-19.
Cron RQ; Caricchio R; Chatham WW
Nat Med; 2021 Oct; 27(10):1674-1675. PubMed ID: 34480126
[No Abstract] [Full Text] [Related]
8. Application of plasma exchange in association with higher dose CVVH in Cytokine Storm Complicating COVID-19.
Lin JH; Chen YC; Lu CL; Hsu YN; Wang WJ
J Formos Med Assoc; 2020 Jun; 119(6):1116-1118. PubMed ID: 32359878
[No Abstract] [Full Text] [Related]
9. Consideration of immunomodulatory actions of morphine in COVID-19 - Short report.
Hudzik B; Nowak J; Zubelewicz-Szkodzinska B
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13062-13064. PubMed ID: 33378059
[TBL] [Abstract][Full Text] [Related]
10. Scoring cytokine storm by the levels of MCP-3 and IL-8 accurately distinguished COVID-19 patients with high mortality.
Chen L; Wang G; Tan J; Cao Y; Long X; Luo H; Tang Q; Jiang T; Wang W; Zhou J
Signal Transduct Target Ther; 2020 Dec; 5(1):292. PubMed ID: 33318472
[No Abstract] [Full Text] [Related]
11. Noradrenergic and serotonergic drugs may have opposing effects on COVID-19 cytokine storm and associated psychological effects.
Fitzgerald PJ
Med Hypotheses; 2020 Nov; 144():109985. PubMed ID: 32554324
[No Abstract] [Full Text] [Related]
12. Can Beta-2-Adrenergic Pathway Be a New Target to Combat SARS-CoV-2 Hyperinflammatory Syndrome?-Lessons Learned From Cancer.
Barbieri A; Robinson N; Palma G; Maurea N; Desiderio V; Botti G
Front Immunol; 2020; 11():588724. PubMed ID: 33117402
[TBL] [Abstract][Full Text] [Related]
13. Is a "Cytokine Storm" Relevant to COVID-19?
Sinha P; Matthay MA; Calfee CS
JAMA Intern Med; 2020 Sep; 180(9):1152-1154. PubMed ID: 32602883
[No Abstract] [Full Text] [Related]
14. [Low dose lung radiotherapy for COVID-19-related cytokine storm syndrome: Why not?].
Cosset JM; Deutsch É; Bazire L; Mazeron JJ; Chargari C
Cancer Radiother; 2020 Jun; 24(3):179-181. PubMed ID: 32389579
[No Abstract] [Full Text] [Related]
15. Etoposide for Cytokine Storm Because of Coronavirus Disease 2019.
Delgado-López PD; Buzón-Martín L; Montero-Baladia M; Astigarraga I
Chest; 2021 Apr; 159(4):1678-1679. PubMed ID: 34021998
[No Abstract] [Full Text] [Related]
16. Cytokine storm and the prospects for immunotherapy with COVID-19.
Calabrese LH
Cleve Clin J Med; 2020 Jun; 87(7):389-393. PubMed ID: 32393592
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms Underlying Potential Therapeutic Approaches for COVID-19.
Benani A; Ben Mkaddem S
Front Immunol; 2020; 11():1841. PubMed ID: 32793246
[TBL] [Abstract][Full Text] [Related]
18. Comment on Hu et al: The cytokine storm and COVID-19.
Faqihi F; Alharthy A; Memish ZA; Karakitsos D
J Med Virol; 2021 Feb; 93(2):631-633. PubMed ID: 32761905
[No Abstract] [Full Text] [Related]
19. A combinatorial approach of a polypharmacological adjuvant 2-deoxy-D-glucose with low dose radiation therapy to quell the cytokine storm in COVID-19 management.
Verma A; Adhikary A; Woloschak G; Dwarakanath BS; Papineni RVL
Int J Radiat Biol; 2020 Nov; 96(11):1323-1328. PubMed ID: 32910699
[TBL] [Abstract][Full Text] [Related]
20. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
